wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33408517-E4E3CDFB-A68E-4980-9CEC-C864B0FFC9DF
Q33408517-E4E3CDFB-A68E-4980-9CEC-C864B0FFC9DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33408517-E4E3CDFB-A68E-4980-9CEC-C864B0FFC9DF
Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management.
P2860
Q33408517-E4E3CDFB-A68E-4980-9CEC-C864B0FFC9DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33408517-E4E3CDFB-A68E-4980-9CEC-C864B0FFC9DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
06c52879489efc0595aeea04c9296fcfeccaf867
P2860
Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia